01 Oct. 2025

Research Funding Manager

Research
Application Starts: 01 Oct. 2025

Champalimaud Foundation is actively looking for a Research Funding Manager. If you are passionate about science and ready to be challenged daily while you help bring some of the most promising research ideas in neuroscience, behaviour, physiology and cancer into reality, this opportunity may be for you.

30 September 2025

7th International Kidney and Monoclonal Gammopathies Meeting held at Champalimaud Foundation

The meeting brought together over 200 specialists from 25 countries, representing a truly international effort to advance research and clinical practice in the field of kidney diseases associated with monoclonal gammopathies.

The scientific programme featured a rich series of sessions addressing key areas in the field, including new pathophysiological insights into monoclonal gammopathies and kidney disease, innovations in diagnostic tools and biomarkers, emerging therapeutic strategies, and the latest updates from ongoing clinical trials.

25 September 2025

Molecular Tools Workshop: Empowering the Next Generation of Molecular Biologists

Blending in-depth lectures with guided laboratory sessions, the workshop offered a dynamic introduction to core molecular biology techniques. Participants engaged directly with methods such as RNA extraction, cDNA synthesis, PCR, restriction enzyme digestion, electrophoresis, plasmid DNA isolation, sequence analysis, and experimental design for cloning projects.

By combining expert instruction with hands-on practice, the programme not only reinforced fundamental concepts but also fostered confidence in applying these tools to real-world research challenges.

24 Sep. 2025

Clinical Laboratory Technician

Research
Application Starts: 24 Sep. 2025

The Cell Centre is looking to expand efforts in the GMP production of cell products with a specific focus on immune-monitoring. 

The successful applicant is expected to be pivotal co-worker in the development and improvement of immune cell-based therapies for malignant diseases and the preparation of GMP compliant production of cellular products including gene-modified immune cells and monitoring of anti-cancer directed vaccination.

DeLIVERing in vivo CRISPR Screens to Study Hepatic Cell-Cell Interactions

Host

Carlos Minutti, PhD, Immunoregulation Lab


Venue

Seminar room

Champalimaud Open Seminar (COpS)

Effective Neural Dynamical System

Memming Park (Neural Dynamics Lab)

 


Moderation

Klaas van Gisbergen (Tissue Immunity Lab)


Venue

Champalimaud Foundation Auditorium 


Registration

Please register via this link.
 

21 August 2025

Tribute to our colleague and friend, Henrique Nabais

With deep sorrow at the passing of Dr. Henrique Nabais, we pay tribute to our colleague and our friend. His unwavering dedication, leadership and professionalism earned him the highest regard and respect from all who knew him. We extend our heartfelt condolences to his family and friends.

Dr. Henrique Nabais led the Gynaecology Unit of the Champalimaud Clinical Centre since 2013. In these years, he left a profound and lasting mark on his colleagues, on the many patients he cared for, and on their families, whose trust he honoured with compassion and excellence.

19 Aug. 2025

Lab Manager at the Cancer Dormancy & Immunity Lab

Research
Application Starts: 19 Aug. 2025

[THIS CALL IS NOW CLOSED]

 

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Lab Manager to join our team at the Champalimaud Research Program. 

The Cancer Dormancy & Immunity Lab, led by Dr. Ana Luisa Correia, at Champalimaud Foundation, Lisbon, Portugal, invites applications for the position of Lab Manager.

16 August 2025

Artificial intelligence can help in the non-invasive diagnosis of prostate cancer

An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging (MRI) scans – that is, without resorting to a biopsy. Their findings were published today, 15th of August, in the journal Radiology: Imaging Cancer.

04 Aug. 2025

Physiotherapist

Research
Application Starts: 04 Aug. 2025

THIS RECRUITMENT PROCESS IS CLOSED.

 

Subscribe to Cancer
Loading
Please wait...